SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-08-001212
Filing Date
2008-11-26
Accepted
2008-11-26 16:15:26
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 arqule-sc13da.htm SC 13D/A 241625
  Complete submission text file 0000898432-08-001212.txt   243728
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address 19 PRESIDENTIAL WAY WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY WOBURN MA 01801 781-994-0300
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48819 | Film No.: 081218165
SIC: 2834 Pharmaceutical Preparations